Cross-industry discussion is expanding from early discovery to post-licensing challenges – as the nexus of innovation and policy improvements is rapidly changing, says DIA executive.

How to prepare for pediatric trials and improve the investigator experience

Jun 27th, 2018 6m 3s

There is an increased need for transparency to improve the conduct of pediatric clinical trials and enhance the site investigator experience, says Syneos executive.

Changing the finish line: Syneos talks bringing payer, patient voice into drug development

Jun 19th, 2018 9m 39s

The drug development “finish line” is not regulatory approval, says Syenos Health chief scientific officer Judith Ng-Cashin, MD, who discusses bringing the payer and patient voice into the process.

PPD: Meeting biopharma demand is a ‘substantial undertaking’ for CRO industry

Jun 7th, 2018 2m 13s

A discussion with The Medical Futurist: AI to take health care 'to the next level’

Apr 23rd, 2018 14m 12s

Dr. Bertalan Mesko discusses the role of artificial intelligence in the future of health care, how patients are driving adoption – and the seemingly thin line between “healing” and “upgrading.”

The future of drug discovery? New tech, a focus on human biology, and partnerships, says Charles River

Nov 6th, 2017 4m 57s

Advanced imaging in drug discovery aims to improve the success rate of drug development as the industry continues to tackle devastating diseases such as Alzheimer’s – but no research lab can do it alone, says Charles River managing director.

Pall: Bioprocessing's future is made of virtual reality

Apr 26th, 2016 1m 33s

EATRIS: Pharma has a vital role in translational medicine

May 28th, 2015 2m 53s

When translational medicine researchers recognise the need for pharma industry cash but are wary of handing over drug development to for-profit organisations, how can public-private collaborations bridge the culture gap?

Happy Holidays 2014 from William Reed Business Media!

Dec 18th, 2014 2m 58s

The holidays are fast upon us, so let’s put ‘business’ to one side and get into the festive mood. To keep in the spirit of things, we’ve got a ‘gift’ for you – enjoy. Happy Holidays!

A bitter pill to swallow: young people dislike tablets more than old

Oct 19th, 2014 3m 13s

Changing pills to a more user-friendly formulation can increase patient compliance, brand loyalty, and extend IP exclusivity, says CMO Hermes in an exclusive podcast.

A bitter pill to swallow: young people dislike tablets more than old

Oct 19th, 2014 3m 13s

Changing pills to a more user-friendly formulation can increase patient compliance, brand loyalty, and extend IP exclusivity, says CMO Hermes in an exclusive podcast.

Consolidation prevalent in industry, says third largest CMO

Mar 26th, 2014 6m 23s

Aenova says the acquisition of Haupt Pharma and Patheon’s merger with DSM are evidence of consolidation in the CMO industry, as it looks to further increase its global footprint.

Catalent commits to ADCs by upping its stake in Redwood

Mar 25th, 2014 4m 36s

Catalent has increased its stake in Redwood Biosciences telling us it is committed to the development of antibody-drug conjugates (ADCs) and the SMARTag technology platform.

Patheon and DSM crossover limited, more growth targeted says DPx

Mar 20th, 2014 4m 1s

Patheon and DSM’s Pharma Products merger is “highly complementary” with crossover limited to North American oral solid manufacturing growth, says DPx as it targets further growth opportunities.

Kemwell CEO says environmental efforts are worth the cost

Nov 26th, 2013 2m 30s

Kemwell CEO Agneta Bergvall says drugmakers' efforts to make pharmaceutical manufacturing green are worth the cost.

Kemwell CEO says environmental efforts are worth the cost

Nov 26th, 2013 2m 30s

Kemwell CEO Agneta Bergvall says drugmakers' efforts to make pharmaceutical manufacturing green are worth the cost.

Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse

Oct 22nd, 2013 4m 51s

Catalent has announced two new softgel solutions as it adds greater versatility to its Advanced Technologies Business Unit.

Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse

Oct 22nd, 2013 4m 51s

Catalent has announced two new softgel solutions as it adds greater versatility to its Advanced Technologies Business Unit.

Kemwell Talks Expansion and Approvals in India and the US

May 26th, 2013 2m 56s

At this year’s Interphex, Kemwell Biopharma spoke to Outsourcing-Pharma.com about recent expansions in both India and the US.

TFS Sees Increase in Modularization, Shorter Construction Timelines

May 20th, 2013 4m 5s

AlpVision's iPhone Tech Offers Authentication in War on Counterfeits

May 6th, 2013 4m 17s

In the war against counterfeits, regulators have concentrated on serialisation and ePedigree and missed an opportunity on product authentication, according to AlpVision.

AlpVision's iPhone Tech Offers Authentication in War on Counterfeits

May 6th, 2013 4m 17s

In the war against counterfeits, regulators have concentrated on serialisation and ePedigree and missed an opportunity on product authentication, according to AlpVision.

AMRI Exec Discusses 'New Bar' in FDA Enforcement

May 1st, 2013 4m 37s

Customers to Save up to 65% as ASI and Chromatan Pen Single-Use Deal

Apr 29th, 2013 4m 38s

ASI has teamed up with Chromatan in order to deliver single-use and column-free capture purification services which could save clients 65% in chromatography costs in clinical manufacturing.

Updated IPEC Guide Steers Excipient Manufacturers Away From Unnecessary Tests

Feb 21st, 2013 7m 18s

Excipient firms that skip lot testing or use alternative analysis methods should justify their decisions according to a new COA guide issued by IPEC Americas.